Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2017

01-11-2017 | Erratum

Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients

Authors: Muneer Ahmed, F. Jozsa, R. Baker, I. T. Rubio, J. Benson, M. Douek

Published in: Breast Cancer Research and Treatment | Issue 2/2017

Login to get access

Excerpt

In the original publication of the article, the corresponding author name was published as Muneer Ahmed. The correct corresponding author of the article is Michael Douek. …
Metadata
Title
Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients
Authors
Muneer Ahmed
F. Jozsa
R. Baker
I. T. Rubio
J. Benson
M. Douek
Publication date
01-11-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4457-4

Other articles of this Issue 2/2017

Breast Cancer Research and Treatment 2/2017 Go to the issue

Brief Report

Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

Clinical trial

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

Epidemiology

Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients

Preclinical Study

Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer

Review

Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients

Clinical Trial

Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits